Skip to content

Evaluate the role of reflexology as adjunctive therapy in the management of children with refractory Childhood Epilepsy including West Syndrome

Evaluation of reflexology as an adjunctive therapy in children with refractory Childhood Epilepsy including West Syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/002944
Enrollment
60
Registered
2010-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Refractory Childhood Epilepsy and West syndrome

Interventions

Intervention1: Reflexology therapy: Reflexology therapy of 30 minutes duration twice a day in addition to the anti-epileptic drugs (AEDs) Control Intervention1: Anti-epileptic drugs (AEDs) alone: Phar

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 6 months to 12 years 2. Presence of seizures persisting daily or more than 7 per week despite the adequate trial of at least three tolerated and appropriately chosen and used anti-epileptic drugs including one newer antiepileptic drug (either alone or in combination). In case of infantile spasms, epileptic spasms with the onset before 2 years of age, with or without electroencephalographic evidence of hypsarrhythmia or its variants, persisting for more than 3 weeks, at least 7 cluster per week, despite treatment with at least 2 appropriate AEDs, and any one of the following; corticosteroids or vigabatrin. 3. Residents of Delhi/National capital region.

Exclusion criteria

Exclusion criteria: 1.Known or suspected inborn error of metabolism, as evidenced by: Clinical suspicion of metabolic disorder as evidenced by 2 or more of the following- a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination And/ or 2 or more of the following biochemical abnormalities High blood ammonia ( >80mmol/L), High arterial lactate ( >2 mmol/L), metabolic acidosis (pH 2.Motivational or psychosocial issues in the family which would preclude compliance. 3.Systemic illness- chronic hepatic, renal or pulmonary disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the efficacy of adjunctive reflexology in controlling seizures. This will be assessed by comparing seizure frequency at the end of the intervention period with the baseline seizure frequency the seizure frequency will be noted according to parental seizure charts.Timepoint: 3 months

Secondary

MeasureTime frame
1.Change in the EEG characteristics and improvement in background of epileptiform abnormalities will be noted. 2.Change in the neural development status at the end of intervention period compared with baseline, in both groups DQ will be assessed far as possible. 3.Change in AFT: Any changes in the HRV and BPV. 4.Abnormalities to be observed in the reflex areas baseline and at the end of the intervention. 5.Side effects of reflexology if any should be noticed by parental report.Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Mrs Sheffali Gulati

Dept of Biophysics

drkrishnadalal@gmail.com011-26593215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026